Quality of Life of Patients with Rheumatic Diseases During the COVID-19 Pandemic: The Biopsychosocial Path
Overview
Authors
Affiliations
Background: Previous models that assess quality-of-Life (QoL) in patients with rheumatic diseases have a strong biomedical focus. We evaluated the impact of COVID-19 related-health care interruption (HCI) on the physical, psychological, social relationships and environment QoL-dimensions, and explored factors associated with QoL when patients were reincorporated to the outpatient clinic, and after six-month follow-up.
Patients And Methods: Study phase-1 consisted of a COVID-19 survey administered from June 24th-October 31st 2020, to outpatients with rheumatic diseases who had face-to-face consultation at outpatient clinic reopening. Study phase-2 consisted of 3 consecutive assessments of patient´s QoL (WHOQOL-BREF), disease activity/severity (RAPID-3), and psychological comorbidity/trauma (DASS-21 and IES-R) to patients from phase-1 randomly selected. Sociodemographic, disease and treatment-related information, and comorbidities were obtained. Multiple linear regression analysis identified factors associated with the score assigned to each WHOQOL-BREF dimension.
Results: Patients included (670 for phase-1 and 276 for phase-2), had primarily SLE and RA (44.2% and 34.1%, respectively), and all the dimensions of their WHOQOL-BREF were affected. There were 145 patients (52.5%) who referred HCI, and they had significantly lower dimensions scores (but the environment dimension score). Psycho-emotional factors (primarily feeling confused, depression and anxiety), sociodemographic factors (age, COVID-19 negative economic impact, years of scholarship, HCI and having a job), and biomedical factors (RAPID-3 score and corticosteroid use) were associated with baseline QoL dimensions scores. Psycho-emotional factors showed the strongest magnitude on dimensions scores. Most consistent predictor of six-month follow-up QoL dimensions scores was each corresponding baseline dimension score, while social determinants (years of scholarship and having a job), emotional factors (feeling bored), and biomedical aspects (RAPID 3) had an additional impact.
Conclusions: HCI impacted the majority of patient´s QoL dimensions. Psycho-emotional, sociodemographic and biomedical factors were consistently associated with QoL dimensions scores, and these consistently predicted the QoL trajectory.
Ledon-Llanes L, Contreras-Yanez I, Guaracha-Basanez G, Valverde-Hernandez S, Cuevas-Montoya M, Ortiz-Haro A PLoS One. 2024; 19(4):e0302284.
PMID: 38669255 PMC: 11051615. DOI: 10.1371/journal.pone.0302284.
Cojocaru C, Popa C, Schenk A, Jakab Z, Suciu B, Olah P Behav Sci (Basel). 2024; 14(4).
PMID: 38667123 PMC: 11047417. DOI: 10.3390/bs14040327.
Adequacy of the WHOQoL-BREF to Assess the Quality of Life of Victims of Armed Conflicts.
Morales-Valiente C, Mok L, Wong A, Manzanero A, Guarch-Rubio M, Simancas M Assessment. 2023; 31(5):1135-1147.
PMID: 37902160 PMC: 11134973. DOI: 10.1177/10731911231201145.
Surviving COVID-19: Biopsychosocial Impacts, Death Anxiety, and Coping Strategies.
Muazzam A, Naseem F, Shakil M, Visvizi A, Klemens J Vaccines (Basel). 2023; 11(3).
PMID: 36992289 PMC: 10057707. DOI: 10.3390/vaccines11030705.
Cox N, Raizada S, Barkham N, Venkatachalam S, Sheeran T, Adizie T Rheumatol Adv Pract. 2023; 7(1):rkad009.
PMID: 36751643 PMC: 9897299. DOI: 10.1093/rap/rkad009.